Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects.

Relvas WG, Izar MC, Helfenstein T, Fonseca MI, Colovati M, Oliveira A, Ihara SS, Han SW, Las Casas AA Jr, Fonseca FA.

Atherosclerosis. 2005 Jan;178(1):101-5.

PMID:
15585206
2.
3.

Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.

Yilmaz H, Agachan B, Karaali ZE, Isbir T.

Int J Mol Med. 2004 Jun;13(6):889-93.

PMID:
15138631
4.
5.

Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.

Rigoli L, Raimondo G, Di Benedetto A, Romano G, Porcellini A, Campo S, Corica F, Riccardi G, Squadrito G, Cucinotta D.

Acta Diabetol. 1995 Dec;32(4):251-6.

PMID:
8750764
6.

A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM.

Atherosclerosis. 2002 Apr;161(2):469-74. Erratum in: Atherosclerosis. 2003 Feb;166(2):415.. Liu Simm [corrected to Liu Simin].

PMID:
11888533
8.
9.

Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease.

Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LH, Humphries SE, Kesäniemi YA.

J Lipid Res. 1995 Apr;36(4):804-12.

10.

Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population.

Sediri Y, Kallel A, Feki M, Mourali S, Elasmi M, Abdessalem S, Mechmeche R, Jemaa R, Kaabachi N.

Eur J Intern Med. 2011 Aug;22(4):407-11. doi: 10.1016/j.ejim.2011.03.002. Epub 2011 Apr 21.

PMID:
21767760
11.

The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.

Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V.

Atherosclerosis. 2001 Nov;159(1):187-92.

PMID:
11689220
12.

Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle.

Boer JM, Feskens EJ, Kuivenhoven JA, Schouten EG, Havekes LM, Kastelein JJ, Seidell JC, Kromhout D.

Atherosclerosis. 2001 Mar;155(1):149-56.

PMID:
11223436
13.

Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia.

Han Z, Heath SC, Shmulewitz D, Li W, Auerbach SB, Blundell ML, Lehner T, Ott J, Stoffel M, Friedman JM, Breslow JL.

Am J Med Genet. 2002 Jul 1;110(3):234-42.

PMID:
12116231
14.

Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group.

Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesäniemi YA, Tahvanainen E, Humphries S.

Eur J Clin Invest. 1999 Feb;29(2):116-28.

PMID:
10092998
15.

Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.

Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.

Diabetes. 1997 Dec;46(12):2082-7.

PMID:
9392500
16.

Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Cardona F, Tinahones FJ, Collantes E, Escudero A, García-Fuentes E, Soriguer FJ.

Ann Rheum Dis. 2005 Jan;64(1):85-8. Epub 2004 Apr 28.

17.

Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis.

Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE.

Atherosclerosis. 1993 May;100(2):157-69.

PMID:
8102848
18.

Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.

Morcillo S, Cardona F, Rojo-Martínez G, Esteva I, Ruíz-de-Adana MS, Tinahones F, Gómez-Zumaquero JM, Soriguer F.

Diabet Med. 2005 Jun;22(6):782-8.

PMID:
15910632
19.

A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men.

Liu S, Song Y, Hu FB, Niu T, Ma J, Gaziano M, Stampfer MJ.

Atherosclerosis. 2004 Nov;177(1):119-26.

PMID:
15488874
20.

A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.

Le Goff W, Guerin M, Nicaud V, Dachet C, Luc G, Arveiler D, Ruidavets JB, Evans A, Kee F, Morrison C, Chapman MJ, Thillet J.

Atherosclerosis. 2002 Apr;161(2):269-79.

PMID:
11888509

Supplemental Content

Support Center